- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00895154
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
2019년 4월 23일 업데이트: Allison King, Washington University School of Medicine
The overall goal of this project is to determine the feasibility of conducting a cognitive intervention for children with sickle cell disease.
연구 개요
상세 설명
The primary aims of this clinical trial are:
- Determine the effectiveness of targeted learning and memory strategy remediation in students with sickle cell disease and cognitive deficits.
- Determine if there is improvement in academic achievement after targeted memory strategy remediation.
연구 유형
중재적
등록 (실제)
21
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
Missouri
-
Saint Louis, Missouri, 미국, 63110
- Washington University School of Medicine/St. Louis Children's Hospital
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
8년 (어린이, 성인)
건강한 자원 봉사자를 받아들입니다
아니
연구 대상 성별
모두
설명
Inclusion Criteria:
- Sickle cell disease that is confirmed by hemoglobin analysis
- Has a brain magnetic resonance imaging (MRI) document reading by a neuroradiologist
- Cognitive deficits, which are defined by one standard deviation lower than the normal ranges of an age-based standard score in cognitive tests that are evaluated by a psychologist
- Must be a student who will remain in school for at least 2 years
- Must provide informed consent with assent in accordance with the institutional policies (institutional review board approval)
Exclusion Criteria:
- Known developmental delays (these participants are ineligible because their learning potential may be biased from a prior insult)
- Intelligent quotient is less than 50 (may have impaired learning potential)
- Aphasic (i.e., unable to produce intelligible speech)
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: General Tutoring Group
Participants will receive general tutoring in the subject of his/her choice.
|
Participants will be tutored for approximately 8-10 hours per month during the school year.
|
|
실험적: Tutoring + Memory Training Group
Participants will receive tutoring and memory training.
|
Participants will be tutored for approximately 8-10 hours per month during the school year.
Participants will receive memory training for approximately 8-10 hours per month during the school year.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Full Scale IQ (FSIQ) (WASI)
기간: After >/= 50 hours of tutoring
|
The WASI is a brief, reliable measure of intelligence.
Participants engage in 4 subtests: Block Design, Vocabulary, Similarities, and Matrix Reasoning.
Participants receive a raw score on each of these 4 subtests.
This raw score is converted to a T score using a score chart in the WASI manual.
The T scores from all 4 subtests are summed together to obtain a Full Scale Sum of T Scores.
This Full Scale Sum of T Scores is converted to a Full Scale IQ-4 Composite Score using a score chart published in the WASI manual.
Higher scores indicate better intelligence.
FSIQ-4 Range: 40-160.
Average FSIQ-4 =100, standard deviation is +/- 15.
|
After >/= 50 hours of tutoring
|
|
Verbal IQ (PIQ) (WASI)
기간: After >/= 50 hours of tutoring
|
The VIQ score is comprised from the Vocabulary and Similarities subtests of the WASI-4.
The raw scores from these subtests are converted to T scores using score charts in the manual.
The T scores are summed together for a Verbal Sum of T Scores.
This score is converted to a Composite VIQ score using a score chart in the manual.
Higher scores = better Verbal IQ.
Range = 45-160.
Average = 100; standard deviation +/- 15.
|
After >/= 50 hours of tutoring
|
|
Performance IQ (PIQ) (WASI)
기간: After >/= 50 hours of tutoring
|
The PIQ score is comprised from the Matrix Reasoning and Block Design subtests of the WASI-4.
The raw scores from these subtests are converted to T scores using score charts in the manual.
The T scores are summed together for a Performance Sum of T Scores.
This score is converted to a Composite PIQ score using a score chart in the manual.
Higher scores = better Performance IQ.
Range = 45-160.
Average = 100; standard deviation +/- 15.
|
After >/= 50 hours of tutoring
|
|
Letter Word Identification T Score (WJ-III)
기간: After >/= 50 hours of tutoring
|
This sub-test measures a student's word identification skills.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Reading Fluency T Score (WJ-III)
기간: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to read simple sentences quickly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Calculations T Score (WJ-III)
기간: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to perform paper and pencil math computations.A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Math Fluency T Score (WJ-III)
기간: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to solve simple addition, subtraction and multiplication facts quickly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Spelling T Score (WJ-III)
기간: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to write orally presented words correctly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
California Verbal Learning Test-Children's Version (CVLT-C) List A Trials 1-5 Immediate Recall T Score
기간: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
CVLT-C Trials 1-5 Semantic Clustering T Score
기간: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The CVLT-C consists of five learning trials of 15 words which can be organized into three semantic categories.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
CVLT-C Trials 1-5 Short Delay Recall T Score
기간: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
CVLT-C Trials 1-5 Long Delay Recall T Score
기간: T scores were obtained at baseline and again at follow-up (after partcipant completed 50 hours of tutoring)
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
T scores were obtained at baseline and again at follow-up (after partcipant completed 50 hours of tutoring)
|
|
CVLT-C Trials 1-5 Recognition Discriminability T Score
기간: After >/= 50 hours of tutoring
|
TThe CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
Delis Kaplan Executive Function System (D-KEFS) Number/Letter Switching T Score
기간: After >/= 50 hours of tutoring
|
The D-KEFS allows for the assessment of executive functions.
There are 9 stand alone tests that can be individually or group administered.
The Number-Letter Switching condition of the Trails Making sub-test specifically assesses flexibility of thinking on a visual-motor sequencing task.
A participant's raw score (# of items answered correctly) is converted to a T score using tables provided in the manual.
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
협력자
수사관
- 수석 연구원: Allison King, MD, MPH, Washington University School of Medicine
간행물 및 유용한 링크
연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.
일반 간행물
- Yerys BE, White DA, Salorio CF, McKinstry R, Moinuddin A, DeBaun M. Memory strategy training in children with cerebral infarcts related to sickle cell disease. J Pediatr Hematol Oncol. 2003 Jun;25(6):495-8. doi: 10.1097/00043426-200306000-00014.
- King AA, White DA, McKinstry RC, Noetzel M, Debaun MR. A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes. Neurology. 2007 Jun 5;68(23):2008-11. doi: 10.1212/01.wnl.0000264421.24415.16.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작
2003년 9월 1일
기본 완료 (실제)
2014년 7월 1일
연구 완료 (실제)
2014년 12월 1일
연구 등록 날짜
최초 제출
2009년 5월 6일
QC 기준을 충족하는 최초 제출
2009년 5월 6일
처음 게시됨 (추정)
2009년 5월 8일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2019년 5월 15일
QC 기준을 충족하는 마지막 업데이트 제출
2019년 4월 23일
마지막으로 확인됨
2019년 4월 1일
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
겸상 적혈구 질환에 대한 임상 시험
-
Sandy SrinivasGlaxoSmithKline완전한방광암 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 절제 가능한 암(방광절제술 전) | 방광(Urothelial, Transitional Cell) 암 표재성(비침습성) | 방광(Urothelial, Transitional Cell) 암 전이성 또는 절제 불가능미국
-
Fondazione Policlinico Universitario Agostino Gemelli...모병상부 요로상피암 | 방광(Urothelial, Transitional Cell) 암 전이성 또는 절제 불가능이탈리아
-
Ankara UniversityFondazione IRCCS Istituto Nazionale dei Tumori, Milano아직 모집하지 않음방광(Urothelial, Transitional Cell) 암 전이성 또는 절제 불가능
-
Ciusss de L'Est de l'Île de MontréalStem Cell Network모병급성 백혈병, 고위험군 | 고위험 골수형성이상증후군 | Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor캐나다
-
Stanford UniversityNational Institutes of Health (NIH)빼는방광암 | 피부암 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 절제 가능한 암(방광절제술 전)미국
-
L2 Bio, LLCFDAMap; Akan Biosciences, Inc.아직 모집하지 않음Crohn & amp;#39; s | Crohn & amp;#39; s Disease (CD)
-
UNC Lineberger Comprehensive Cancer CenterFogarty International Center of the National Institute of Health모집하지 않고 적극적으로
-
Relmada Therapeutics, Inc.빼는요로상피암 방광 | 비뇨기과 암 | 요로상피암 재발성 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 암 표재성(비침습성)
-
Vanderbilt University Medical CenterTakeda Pharmaceuticals U.S.A., Inc.모집하지 않고 적극적으로염증성 장질환(IBD) | 궤양성 대장염(UC) | Crohn & amp;#39; s Disease (CD)미국
General Tutoring에 대한 임상 시험
-
Consorci d'Atenció Primària de Salut de l'Eixample완전한
-
Khyber Medical University PeshawarKhyber Teaching Hospital; Northwest General Hospital and Research centre모병
-
Consorci d'Atenció Primària de Salut de l'EixampleMedtronic완전한
-
University Hospital, Clermont-Ferrand알려지지 않은
-
Boston Children's HospitalGeneral Electric완전한발육부전 좌심장 증후군 | 대혈관의 전위 | 혈역학의 산소 소비 기반 평가미국